Royal Marsden NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Evaluating a Digital Tool for Supporting Breast Cancer Patients
Not Applicable
- Conditions
- Breast Cancer
- Interventions
- Device: OWise
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 165
- Registration Number
- NCT03866655
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Lifestyle Changes Using Digital Technology in Colorectal Cancer
Not Applicable
- Conditions
- Life StyleColo-rectal Cancer
- Interventions
- Behavioral: Lifestyle changes with the support of health technology
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 20
- Registration Number
- NCT03849352
A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
- Conditions
- Pancreatic Adenocarcinoma
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 200
- Registration Number
- NCT03840460
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Value of Analysing Under-utilised Leftover Tissue (VauLT)
Recruiting
- Conditions
- Oncology
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 800
- Registration Number
- NCT03832062
- Locations
- 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer
Phase 2
- Conditions
- Oesophageal CancerGastro-Oesophageal Junction CancerGastric Cancer
- Interventions
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 54
- Registration Number
- NCT03829345
- Locations
- 🇬🇧
Claire Saffery, Sutton, United Kingdom
Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer
Phase 3
Terminated
- Conditions
- POLE Exonuclease Mutant Colon CancerMicrosatellite InstabilityStage III Colon Cancer
- Interventions
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 30
- Registration Number
- NCT03827044
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE)
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 75
- Registration Number
- NCT03812796
- Locations
- 🇬🇧
The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
Gustatory Function Following Radiotherapy to the Head and Neck
- Conditions
- Head and Neck Cancer
- Interventions
- Other: Olfactory screeningOther: Quantative Gustatory Testing using Taste Strips
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2018-11-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 110
- Registration Number
- NCT03738657
- Locations
- 🇬🇧
Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
Completed
- Conditions
- MammographyMRIBRCA2 MutationBRCA1 Mutation
- Interventions
- Diagnostic Test: MRI
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 28
- Registration Number
- NCT03684733
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)
Not Applicable
- Conditions
- Prostate Cancer
- Interventions
- Device: MR LINAC
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 30
- Registration Number
- NCT03658525
- Locations
- 🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath